Colfax Schedules Third Quarter 2021 Earnings Release and Conference Call
Colfax Corporation (NYSE: CFX) will announce its third-quarter 2021 financial results on November 4, 2021. A public conference call is scheduled for 8:00 a.m. Eastern, accessible via phone and webcast. The earnings release and any supplemental information will be available on Colfax's website prior to the call. Additionally, Colfax is undergoing a strategic separation into two independent companies focusing on specialty medical technologies and fabrication technologies, aiming to enhance value creation by Q1 2022.
- Scheduled financial results release for Q3 2021 on November 4, 2021.
- Company undergoing strategic separation to enhance value creation, expected completion in Q1 2022.
- None.
WILMINGTON, DE, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the third quarter of 2021 on the morning of Thursday, November 4, 2021. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-888-771-4371 (U.S. callers) and +1-847-585-4405 (International callers) and referencing the conference ID number 50243903 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.
Colfax’s financial results press release and supplemental information referenced on the call, if any, for the third quarter of 2021 will be available under the “Investors” section of Colfax’s website prior to the conference call. A link to a replay of the call will also be available on the Colfax website later that day.
About Colfax Corporation
Colfax Corporation (NYSE: CFX) is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System (“CBS”), a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies, which is targeted to be completed in the first quarter of 2022 to accelerate strategic momentum and unlock additional value creation potential; one business will focus on specialty medical technologies and the other on fabrication technologies. For more information about Colfax and our separation activities, please visit www.colfaxcorp.com.
FAQ
When will Colfax Corporation release its Q3 2021 financial results?
What time is the Colfax conference call for discussing financial results?
What is the purpose of Colfax's strategic separation?
Where can I find the financial results for Colfax Corporation?
